Alpha Cognition Inc. (ACOG)
| Market Cap | 138.93M+15.9% |
| Revenue (ttm) | n/a+232.7% |
| Net Income | n/a-17.1% |
| EPS | n/a+30.6% |
| Shares Out | 15.53M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,151.463 |
| Open | 8.98 |
| Previous Close | 9.04 |
| Day's Range | 8.85 - 9.09 |
| 52-Week Range | 4.50 - 10.14 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 17.25(+92.85%) |
| Earnings Date | n/a |
Alpha Cognition Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About ACOG
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. Alpha Cognition Inc. was founded in 2000 and is headquartered in Grapevine, Texas.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ACOG stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ACOG holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ACOG's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ACOG Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ACOG patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ACOG from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ACOG
| ETF | Est. Holding Size |
|---|---|
| AVSCAvantis U.S. Small Cap Equity ETF | $78.13K |
Estimated from each fund’s disclosed top holdings × AUM
ACOG Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ACOG’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score